318 related articles for article (PubMed ID: 3274444)
21. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
[No Abstract] [Full Text] [Related]
22. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy.
Taylor CJ; Bayne AM; Welsh KI; Morris PJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273
[No Abstract] [Full Text] [Related]
23. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
[No Abstract] [Full Text] [Related]
24. Is the routine use of induction immunosuppression with ALG or OKT3 justified in cadaveric renal transplantation?
Mozes MF; Venkat KK; Kupin W; Dumler F; Gracida C; Uniewski M; Anaise D; Tang DH
Transplant Proc; 1993 Feb; 25(1 Pt 1):575-6. PubMed ID: 8438420
[No Abstract] [Full Text] [Related]
25. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
[No Abstract] [Full Text] [Related]
26. The impact of immunological risk factors on the outcome of cadaveric renal transplantation as revealed in transplants with primary graft anuria.
Madsen M; Fjeldborg O; Rasmussen A; Povlsen JV; Kissmeyer-Nielsen F
Transplant Proc; 1990 Aug; 22(4):1371-2. PubMed ID: 2389332
[No Abstract] [Full Text] [Related]
27. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
[No Abstract] [Full Text] [Related]
28. The impact of induction therapy HLA matching and T- and B-cell crossmatch on the long-term outcome of living donated renal transplantation.
Lumlertgul D; Manoyos A; Saikum U; Chaovisitsaree A; Boonkaew S; Wongsawad P; Bunnachak D; Roachanapiwat B; Wutikarn S
Transplant Proc; 1998 Aug; 30(5):1801-4. PubMed ID: 9723290
[No Abstract] [Full Text] [Related]
29. HLA-DR matching and B-cell crossmatching in renal transplantation.
Ting A; Williams KA; Morris PJ
Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
[No Abstract] [Full Text] [Related]
30. Is long-term triple drug therapy required for maintaining kidney allograft tolerance? Effect of azathioprine withdrawal at three months posttransplantation.
Oncevski A; Rostoker G; Buisson C; Fruchaud G; Benmaadi A; Belghiti D; Chopin D; Abbou C; Bierling P; Romano P
Transplant Proc; 1989 Feb; 21(1 Pt 2):1625-6. PubMed ID: 2652529
[No Abstract] [Full Text] [Related]
31. Prospective HLA typing is helpful in cadaveric renal transplantation.
van Rood JJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):139-43. PubMed ID: 3547809
[No Abstract] [Full Text] [Related]
32. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.
Abramowicz D; Norman DJ; Goldman M; De Pauw L; Kinnaert P; Kahana L; Thistlethwaite JR; Shield CF; Monaco AP; Vanherweghem JL
Transplant Proc; 1995 Feb; 27(1):852-3. PubMed ID: 7879204
[No Abstract] [Full Text] [Related]
33. Improved results of renal transplantation in diabetic nephropathy.
Wilczek H; Gunnarsson R; Lundgren G; Ost L
Transplant Proc; 1984 Jun; 16(3):623-7. PubMed ID: 6375029
[No Abstract] [Full Text] [Related]
34. Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy.
Persijn GG; D'Amaro J; de Lange P; Schreuder GM; van Rood JJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):656-8. PubMed ID: 2650212
[No Abstract] [Full Text] [Related]
35. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients.
Opelz G; Schwarz V; Engelmann A; Back D; Wilk M; Keppel E
Transplant Proc; 1991 Feb; 23(1 Pt 1):373-5. PubMed ID: 1990556
[No Abstract] [Full Text] [Related]
36. Coenzyme Q, alpha tocopherol and delayed function in human kidney transplantation.
Serino F; Citterio F; Lippa S; Oradei A; Agnes S; Nanni G; Pozzetto A; Littarru G; Castagneto M
Transplant Proc; 1990 Aug; 22(4):1375-8. PubMed ID: 2389334
[No Abstract] [Full Text] [Related]
37. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
[No Abstract] [Full Text] [Related]
38. HLA-DR1 recipients have the highest kidney transplant survival.
Cook DJ; Cecka JM; Terasaki PI
Transplant Proc; 1987 Feb; 19(1 Pt 1):675-7. PubMed ID: 3274837
[No Abstract] [Full Text] [Related]
39. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
[No Abstract] [Full Text] [Related]
40. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
